ATE44529T1 - Substituierte hexahydroarylchinolizine. - Google Patents

Substituierte hexahydroarylchinolizine.

Info

Publication number
ATE44529T1
ATE44529T1 AT85100732T AT85100732T ATE44529T1 AT E44529 T1 ATE44529 T1 AT E44529T1 AT 85100732 T AT85100732 T AT 85100732T AT 85100732 T AT85100732 T AT 85100732T AT E44529 T1 ATE44529 T1 AT E44529T1
Authority
AT
Austria
Prior art keywords
substituted
hexahydroarylquinolizine
antidiabetics
antihypertensives
antidepressants
Prior art date
Application number
AT85100732T
Other languages
English (en)
Inventor
Joel R Huff
Joseph P Vacca
John J Baldwin
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE44529T1 publication Critical patent/ATE44529T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT85100732T 1984-02-02 1985-01-25 Substituierte hexahydroarylchinolizine. ATE44529T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57623384A 1984-02-02 1984-02-02
EP85100732A EP0154142B1 (de) 1984-02-02 1985-01-25 Substituierte Hexahydroarylchinolizine

Publications (1)

Publication Number Publication Date
ATE44529T1 true ATE44529T1 (de) 1989-07-15

Family

ID=24303506

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85100732T ATE44529T1 (de) 1984-02-02 1985-01-25 Substituierte hexahydroarylchinolizine.

Country Status (15)

Country Link
EP (1) EP0154142B1 (de)
JP (1) JPS60188385A (de)
KR (1) KR900003651B1 (de)
AT (1) ATE44529T1 (de)
AU (1) AU576550B2 (de)
CA (1) CA1240677A (de)
DE (1) DE3571438D1 (de)
DK (1) DK45385A (de)
ES (1) ES8609323A1 (de)
GR (1) GR850211B (de)
IE (1) IE850253L (de)
IL (1) IL74147A (de)
NZ (1) NZ210982A (de)
PT (1) PT79871B (de)
ZA (1) ZA85789B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4690928A (en) * 1984-02-02 1987-09-01 Merck & Co., Inc. Substituted hexahydro arylquinolizines as α2 blockers
GB8420602D0 (en) * 1984-08-14 1984-09-19 Wyeth John & Brother Ltd Thienoquinolizines
DK127086A (da) * 1985-03-25 1986-09-26 Schering Corp Substituerede 1,8-naphthyridoner, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner, der indeholder disse forbindelser
AU582663B2 (en) * 1985-08-10 1989-04-06 John Wyeth & Brother Limited Sulphonamides
US4686226A (en) * 1985-09-03 1987-08-11 Merck & Co., Inc. Substituted benzo[b]furo- and benzo[b]thieno quinolizines
US4835276A (en) * 1986-07-03 1989-05-30 Merck & Co., Inc. Preparation of n-formamidoyl[(s)-1-t-butoxy-3-methyl-2-amino)]1,2,3,4 tetrahydrobenzo [b]furo [2,3-c]pyridine and derivatives
US4814452A (en) * 1986-07-03 1989-03-21 Merck & Co., Inc. Enantioselective synthesis of 1,3,4,6,7,12b(S)-hexahydro-2H-benzo[b]furo[2,3-a]quinolizin-2-one
NZ221485A (en) * 1986-08-28 1991-04-26 Merck & Co Inc Hexahydroarylquinolizine derivatives and pharmaceutical compositions
US4831035A (en) * 1986-08-28 1989-05-16 Merck & Co., Inc. Substituted hexahydroarylquinolizines
US4956365A (en) * 1987-04-13 1990-09-11 Syntex (U.S.A.) Inc. Decahydro-8H-isoquino(2,1-g)(1,6)naphthyridine derivatives and related compounds
CA1321751C (en) * 1989-02-21 1993-08-31 Eugene C. Crichlow Mechanism mediating ruminal stasis in ruminal lactic acidosis
EP2507244B1 (de) 2009-12-04 2014-11-05 Nerviano Medical Sciences S.r.l. Tricyclopyrazolderivate
GB201509006D0 (en) 2015-05-26 2015-07-08 Redx Pharma Plc Antibacterial compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1470065C3 (de) * 1961-06-19 1980-07-17 Merck Patent Gmbh, 6100 Darmstadt Verfahren zur Herstellung von Chinolizinderivaten
GB1435573A (en) * 1973-05-25 1976-05-12 Wyeth John & Brother Ltd Indoloquinolizines
US4181657A (en) * 1978-07-14 1980-01-01 Miles Laboratories, Inc. 2-Aminooctahydroindolo[2,3-a]quinolizines useful in treating cardiovascular disorders
GB2106909B (en) * 1981-10-07 1984-09-19 Wyeth John & Brother Ltd Benzoquinolizines

Also Published As

Publication number Publication date
KR850005843A (ko) 1985-09-26
CA1240677A (en) 1988-08-16
AU3822085A (en) 1985-08-08
EP0154142B1 (de) 1989-07-12
AU576550B2 (en) 1988-09-01
DK45385D0 (da) 1985-02-01
ES8609323A1 (es) 1986-07-16
ZA85789B (en) 1986-09-24
IL74147A0 (en) 1985-04-30
IL74147A (en) 1988-08-31
GR850211B (de) 1985-05-24
EP0154142A1 (de) 1985-09-11
DK45385A (da) 1985-09-18
JPS60188385A (ja) 1985-09-25
KR900003651B1 (ko) 1990-05-28
DE3571438D1 (en) 1989-08-17
PT79871A (en) 1985-02-01
IE850253L (en) 1985-08-02
NZ210982A (en) 1988-04-29
PT79871B (en) 1986-12-15
ES539799A0 (es) 1986-07-16

Similar Documents

Publication Publication Date Title
DE3688651D1 (de) Undurchlaessige, unter waerme klebende sperrschicht.
NO894086D0 (no) Fremgangsmaate for fremstilling av piperidinylbenzimidazoler.
DE58901039D1 (de) Selbstspannendes bohrfutter.
ATE44529T1 (de) Substituierte hexahydroarylchinolizine.
NL970029I2 (nl) Benzimidazoolderivaten, bereiding en therapeutische toepassing.
NO890579D0 (no) ((5(6) (1h-azol-1-ylmetyl)benzimidazol)karbamater.
GR76413B (de)
DE58906668D1 (de) Spannzange.
DE58907381D1 (de) Ungesättigte Derivate von 2,2,6,6-Tetramethylpiperidin.
DE3867598D1 (de) Zweipol-halbleiterdiode.
FI890824A (fi) Foerfarande foer framstaellning av skivor av mineralglas med hoeg genomslaeppning i det synliga spektralomraodet och laog genomslaeppning av solenergi och med detta foerfarande framstaellda skivor.
ES8707729A1 (es) Un procedimiento para la preparacion de hexahidroarilquinolizinas sustituidas.
DE58901804D1 (de) Spannzange.
DE68928670D1 (de) Heterostrukturbipolartransistor
NO892772L (no) Nye 1,4-diazepinderivater med anti-ulcusaktivitet.
DE69004455D1 (de) Alpha-adrenergene Rezeptor-Antagonisten.
FI893211A (fi) Antihypertensiva, n-terminala eteraminodiolamino-syraderivat.
SE8704272L (sv) Pharmaceutisk komposition
NO883533D0 (no) Kutterring for tunnelboring i fjell.
ES1009394Y (es) Cabezal mandrinador.
NO874734L (no) Nye peptidderivater.
ATE61952T1 (de) Ausdrehkopf.
IT8463254V0 (it) Impalcatura semovente per lavori di restauro, imbiancatura e simili.
ATE80073T1 (de) Bohrkopf.
IT8820979V0 (it) Dispositivo atto a permettere la realizzazione di una sedia a sdraio per sciatori.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee